Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Equity (2024 - 2025)

Indivior Pharmaceuticals has reported Return on Equity over the past 2 years, most recently at 1.38% for Q4 2025.

  • Quarterly results put Return on Equity at 1.38% for Q4 2025, down 136.0% from a year ago — trailing twelve months through Dec 2025 was 1.38% (down 136.0% YoY), and the annual figure for FY2025 was 0.97%, down 94.0%.
  • Return on Equity for Q4 2025 was 1.38% at Indivior Pharmaceuticals, down from 0.56% in the prior quarter.
  • Over the last five years, Return on Equity for INDV hit a ceiling of 0.16% in Q2 2024 and a floor of 1.38% in Q4 2025.